Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579930 · ClinicalTrials.gov registry record
Cytogenetic and Molecular Genetic Studies in Bone Sarcomas
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1
- Enrollment target
NCT00579930: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579930 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579930 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
To establish a serial ascertainement of specimens from patients with bone sarcomas to be used in ongoing cytogenetic and molecular genetic analyses. These data will be integrated and correlated with the established Orthopaedic Service clinical database.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 1993-12 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579930
The ClinicalTrials.gov registry entry for NCT00579930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00579930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579930 about?
NCT00579930 is a clinical study titled "Cytogenetic and Molecular Genetic Studies in Bone Sarcomas". To establish a serial ascertainement of specimens from patients with bone sarcomas to be used in ongoing cytogenetic and molecular genetic analyses. These data will be integrated and correlated with the established Orthopaedic Service clinical database.
What is the current status of trial NCT00579930?
This trial is currently completed. The enrollment target is 1 participants. The study started on 1993-12. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT00579930?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.